Morimoto, Yoshihiro
Mizushima, Tsunekazu
Wu, Xin
Okuzaki, Daisuke
Yokoyama, Yuhki
Inoue, Akira
Hata, Tsuyoshi
Hirose, Haruka
Qian, Yamin
Wang, Jiaqi
Miyoshi, Norikatsu
Takahashi, Hidekazu
Haraguchi, Naotsugu
Matsuda, Chu
Doki, Yuichiro
Mori, Masaki
Yamamoto, Hirofumi
Article History
Received: 21 August 2019
Revised: 31 December 2019
Accepted: 30 January 2020
First Online: 18 February 2020
Ethics approval and consent to participate
: All animal experiments were performed in accordance with currently prescribed guidelines and followed a protocol approved by Osaka University. This study was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients, and the study was approved by the Ethics Board of Osaka University Hospital.
: Informed consent was obtained from all patients for publication of this article.
: The expression levels of miR-4711-5p and other miRNAs referred to in this study (Supplementary Fig. InternalRef removed) are available on the Tissue Atlas website (ExternalRef removed). The expression levels of KLF5 referred to in this study (Supplementary Fig. InternalRef removed) are available on the Human Protein Atlas website (ExternalRef removed). All the other data of the study can be found with the corresponding author.
: The authors declare no competing interests.
: This work was supported by a grant from Kagoshima Shinsangyo Sousei Investment Limited Partnership (its general partner is Kagoshima Development Co., Ltd).